During our screening program for a secondary metabolite with a polycyclic ring system from a bacterial species using LC-MS/UV-based chemical analysis, the production of a novel b-hydroxyl-d-lactone compound, neomacquarimicin (1), with a molecular ion at m/z 317.1756 and an absorption maximum at 279 nm, was observed in the culture extract of Micromonospora sp. NPS2077, which was isolated from an unidentified marine sponge collected at Uranouchi Bay, Kochi, Japan. Herein, we report the fermentation, isolation, structural elucidation, and biological properties of 1.
MS and UV-guided chromatographic purification steps, reverse-phase chromatography (3.5 Â 7 cm 2 , Wako gel C-50, Wako) with aqueous methanol solution (25-100% aq. MeOH in 25% stepwise increments), and partitioned TLC chromatography (0.5 mm, silica gel 60 F 254 ; Merck, Darmstadt, Germany) with an EtOAc/methanol (19/1) solution were performed to afford a pure sample of neomacquarimicin (1, 4.8 mg) with an R f value in EtOAc:MeOH (19:1) of 0.79.
The molecular ion of m/z 317.1756 for neomacquarimicin was determined by HR-ESI-time-of-flight positive-ion MS. The 13 C NMR and HSQC spectra of neomacquarimicin indicated 19 carbon atoms with 23 attached protons and suggested the presence of functional groups, including a ketone (d C 219.1, qC), an ester (d C 175.5, qC) and an olefin (d C 130.6, CH; d C 123.3, CH). Thus, the MW could represent a molecular formula of C 19 H 24 O 4 with five rings. The 2D homonuclear and heteronuclear NMR experiments showed connectivities consistent with a structure possessing portions similar to macquarimicin C (2) 3 but with desorption of the methyl ketone at C-9 and reduction of the ketone at C-19, as shown in Figure 1 -I. The 1D ( 1 H and 13 C) NMR spectral data and 2D NMR correlations for 1 are summarized in Table 1 .
Key HMBC correlations were observed for the H-1 methine proton (d H 4.65) with the 13 C NMR signals at d C 175.5 (C-3), 23.4 (C-16) and 68.9 (C-19) and for the H-6 methine proton (d H 2.43) with the 13 C NMR signals at d C 28.4 (C-5), 38.5 (C-7), 46.2 (C-11), 130.6 (C-13) and 29.9 (C-14).
The relative configuration of neomacquarimicin was determined by NOESY experiments and from the J values. The NOE correlations observed in these experiments are summarized in Figure 1 -II. The coupling constant of J 7, 8ab (6.8 Hz) and J 8ab, 9 (7.3, 6.9 Hz) supported by the NOE correlations among 5-H, 7-H and 11-H confirmed that the AB ring junction was cis. The BC ring junction was also proved to be cis by the COSY correlation between H-14 and H-15a and the NOE network in H-6/Hb-8 and H-15a/H-13. The relative stereochemistry of the cyclopentane ring (A ring) and the cyclohexane rings (C and D rings) was determined by the NOE correlations observed among H-11/H-9, H-20/H-8b, H-6/H-8b/H-5a, H-5b/H-7 and H-19/H-5a. The relative configuration of neomacquarimicin was determined from these results, as shown in Figure 1 -II.
The absolute configuration of 1 was determined using the modified Mosher's method. 4 Neomacquarimicin was esterified to give the corresponding (R)-and (S)-MTPA esters 1a and 1b, respectively. According to the analysis of the Mosher ester, the absolute stereochemistry of 1 was determined to be S at C-4, C-6, C-11, C-14, C-16 and C-19, and R at C-1, C-7 and C-9 ( Figure 1-II) . Thus, the relative and absolute configurations of 1 corresponded completely.
Neomacquarimicin is characterized by its b-hydroxy-d-lactone structure. However, the other moieties of 1 are similar to those in cochleamycin B 5 and macquarimicin C; thus, several of these compounds might have a biosynthetic relationship to 1. Cochleamycins and macquarimicins, both of which are metabolites of actinomycetes, are carbocyclic polyketides with a b-keto-d-lactone unit. The biosynthetic origin of cochleamycin has been confirmed by incorporation of 13 C-labeled precursors. 6 Starting from the plausible polyketide intermediate shown in Figure 1 -III, oxidation followed by the intramolecular Diels-Alder reaction of the triene could form tetrahydroindane. Aldol condensation of tetrahydroindane followed by dehydration could produce the four-ring fused structure in macquarimicin A and cochleamycin A. A reductive transannular cyclization reaction could generate the five-ring fused structure in macquarimicin C and cochleamycin B. Similar to these biosynthetic pathways, a ketone reduction is necessary, in addition to C-C bond formation by PKS, for the construction of the b-hydroxy-d-lactone of 1. The stereochemistry of H-9 suggests that the reduction of C-19 occurs during the final step. Attempts to obtain key intermediates are currently underway.
Neomacquarimicin (1) was evaluated for inhibitory activity on human acidic sphingomyelinase and rat neutral sphingomyelinase (rnSMase) at concentrations from 0.07 to 700 mM, but no significant responses were noted. In addition, the in vitro cytotoxic activity of 1 was evaluated against human umbilical vein endothelial cells, and no cytotoxicity was observed when the cells were exposed to 350 mM 1 for 3 days. The compound 1 was evaluated for activity in the Bacillus subtilis ATCC 43223 and Escherichia coli ATCC 10536 microbial assays at concentrations that range from 50 to 0.50 mM. Unfortunately, no significant responses were noted at the concentrations tested. A large member of carbocyclic polyketides with a b-keto-d-lactone unit showed cytotoxicity and antimicrobial activity. [7] [8] [9] In addition, macquarimicin A is a weak yet specific inhibitor of rnSMase (IC 50 value: 145.8 mM). 10 Results on our ongoing structure activity correlation of b-hydroxy-d-lactone unit will be reported in a forthcoming paper. 
